R. Travis Taylor

1.0k total citations
22 papers, 649 citations indexed

About

R. Travis Taylor is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, R. Travis Taylor has authored 22 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Immunology. Recurrent topics in R. Travis Taylor's work include Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (9 papers) and interferon and immune responses (5 papers). R. Travis Taylor is often cited by papers focused on Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (9 papers) and interferon and immune responses (5 papers). R. Travis Taylor collaborates with scholars based in United States, Sweden and Switzerland. R. Travis Taylor's co-authors include Wade A. Bresnahan, Sonja M. Best, Shelly J. Robertson, Marshall E. Bloom, Peter Šťastný, Yizhou Zou, Kirk J. Lubick, James P. Broughton, Dana Mitzel and Isabel S. Novella and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

R. Travis Taylor

21 papers receiving 640 citations

Peers

R. Travis Taylor

IMMUN

EPIDE

PHEOH

PARAS

Yiquan Wu China

Clémence Richetta France

Kristen Monte United States

Felix Geeraedts Netherlands

Naganori Kamiyama Japan

Hyelim Cho United States

Wen Pan China

Sara C. Smelt United Kingdom

Daniel Fernandez‐Ruiz Australia

Mónica Mondragón‐Castelán Mexico

Yiquan Wu China

R. Travis Taylor

196 ×0.6

IMMUN

302 ×1.0

EPIDE

97 ×0.5

291 ×1.6

PHEOH

134 ×1.0

PARAS

Citations per year, relative to R. Travis Taylor R. Travis Taylor (= 1×) peers Yiquan Wu

Countries citing papers authored by R. Travis Taylor

Since Specialization

Citations

This map shows the geographic impact of R. Travis Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Travis Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Travis Taylor more than expected).

Fields of papers citing papers by R. Travis Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Travis Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Travis Taylor. The network helps show where R. Travis Taylor may publish in the future.

Co-authorship network of co-authors of R. Travis Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of R. Travis Taylor. A scholar is included among the top collaborators of R. Travis Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Travis Taylor. R. Travis Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kabir, Mohammad Hazzaz Bin, et al.. (2025). Identification of TRIM21 and TRIM14 as Antiviral Factors Against Langat and Zika Viruses. Viruses. 17(5). 644–644.

Taylor, R. Travis, et al.. (2024). IRF3 inhibits inflammatory signaling pathways in macrophages to prevent viral pathogenesis. Science Advances. 10(32). eadn2858–eadn2858. 8 indexed citations

Harris, Ryan A., et al.. (2024). Retinoic Acid-Mediated Inhibition of Mouse Coronavirus Replication Is Dependent on IRF3 and CaMKK. Viruses. 16(1). 140–140. 1 indexed citations

Borucki, Monica K., Merina Varghese, James B. Thissen, et al.. (2022). SARS-CoV-2 Monitoring in Wastewater Reveals Novel Variants and Biomarkers of Infection. Viruses. 14(9). 2032–2032. 5 indexed citations

O’Donovan, Sinead M., Ali Sajid Imami, Justin F. Creeden, et al.. (2021). Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach. Scientific Reports. 11(1). 4495–4495. 20 indexed citations

Burlak, Christopher, R. Travis Taylor, Zheng‐Yu Wang, & A. Joseph Tector. (2020). Human anti‐α‐fucose antibodies are xenoreactive toward GGTA1/CMAH knockout pigs. Xenotransplantation. 27(6). e12629–e12629. 4 indexed citations

Subramanian, G. Mani, et al.. (2020). The interferon-inducible protein TDRD7 inhibits AMP-activated protein kinase and thereby restricts autophagy-independent virus replication. Journal of Biological Chemistry. 295(20). 6811–6822. 18 indexed citations

Chawla, Karan, G. Mani Subramanian, Julie Garcia, et al.. (2020). High Throughput Screening of FDA-Approved Drug Library Reveals the Compounds that Promote IRF3-Mediated Pro-Apoptotic Pathway Inhibit Virus Replication. Viruses. 12(4). 442–442. 13 indexed citations

Chiramel, Abhilash I., Nicholas R. Meyerson, Kristin L. McNally, et al.. (2019). TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation. Cell Reports. 27(11). 3269–3283.e6. 54 indexed citations

10.

Youseff, Brian H., Thomas G. Brewer, Kristin L. McNally, et al.. (2019). TRAF6 Plays a Proviral Role in Tick-Borne Flavivirus Infection through Interaction with the NS3 Protease. iScience. 15. 489–501. 7 indexed citations

11.

McNally, Kristin L., Stephen Harris, Brian H. Youseff, et al.. (2017). Interferon signaling in Peromyscus leucopus confers a potent and specific restriction to vector-borne flaviviruses. PLoS ONE. 12(6). e0179781–e0179781. 10 indexed citations

12.

Chiramel, Abhilash I., Logan Banadyga, Darryl Falzarano, et al.. (2016). Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga. The Journal of Infectious Diseases. 214(suppl 3). S355–S359. 6 indexed citations

13.

Novella, Isabel S., et al.. (2014). RNA replication errors and the evolution of virus pathogenicity and virulence. Current Opinion in Virology. 9. 143–147. 23 indexed citations

14.

Taylor, R. Travis & Sonja M. Best. (2011). Assessing ubiquitination of viral proteins: Lessons from flavivirus NS5. Methods. 55(2). 166–171. 9 indexed citations

15.

Taylor, R. Travis, Kirk J. Lubick, Shelly J. Robertson, et al.. (2011). TRIM79α, an Interferon-Stimulated Gene Product, Restricts Tick-Borne Encephalitis Virus Replication by Degrading the Viral RNA Polymerase. Cell Host & Microbe. 10(3). 185–196. 75 indexed citations

16.

Robertson, Shelly J., Dana Mitzel, R. Travis Taylor, Sonja M. Best, & Marshall E. Bloom. (2008). Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures. Immunologic Research. 43(1-3). 172–186. 55 indexed citations

17.

Taylor, R. Travis & Wade A. Bresnahan. (2006). Human Cytomegalovirus IE86 Attenuates Virus- and Tumor Necrosis Factor Alpha-Induced NFκB-Dependent Gene Expression. Journal of Virology. 80(21). 10763–10771. 63 indexed citations

18.

Taylor, R. Travis & Wade A. Bresnahan. (2005). Human Cytomegalovirus Immediate-Early 2 Protein IE86 Blocks Virus-Induced Chemokine Expression. Journal of Virology. 80(2). 920–928. 78 indexed citations

19.

Zou, Yizhou, Wade A. Bresnahan, R. Travis Taylor, & Peter Šťastný. (2005). Effect of Human Cytomegalovirus on Expression of MHC Class I-Related Chains A. The Journal of Immunology. 174(5). 3098–3104. 81 indexed citations

20.

Taylor, R. Travis & Wade A. Bresnahan. (2005). Human Cytomegalovirus Immediate-Early 2 Gene Expression Blocks Virus-Induced Beta Interferon Production. Journal of Virology. 79(6). 3873–3877. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact